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Lindholt et al.1 extended the analysis of the Viborg
Country trial. A previous systematic review by
Fleming et al.2 concluded that an invitation to attend
abdominal aortic aneurysm (AAA) screening reduced
not all-cause but AAA-related mortality for men age
65 to 75 years. Fleming et al., however, did not include
outcomes for 10 years of follow-up reported by the
Chichester trial and the Viborg Country trial. There-
fore, we performed meta-analyses of currently
available randomized, controlled trials including 10
year results from the Chichester trial and the Viborg
Country trial.
We searched the topic of AAA in MEDLINE and
identified 4 randomized, controlled trials (Table 1).
Only randomized population-based trials that com-
pared screening with unscreened controls and1078–5884/000132+ 02 $32.00/0  2006 Published by Elsevier Ltd.reported AAA-related and all-cause mortality in
men were included. All trials had odds ratios
(ORs) favoring an association between an invitation
to attend screening and a reduction in AAA-related
mortality, and the association was significant in 2
trials. The pooled OR showed a reduction in AAA-
related mortality favoring screening (OR, 0.55; 95%
confidence interval [CI], 0.37e0.83). All but one trials
had ORs favoring an association between an invitation
to attend screening and a reduction in all-cause mor-
tality, and the association was significant in one trial.
When the results were pooled, an invitation to attend
screening was associated with a non-significant
reduction in all-cause mortality (OR, 0.95; 95% CI,
0.87e1.03).
The present meta-analyses of currently available
randomized, controlled trials demonstrated that an
invitation to attend AAA screening reduced not all-
cause but AAA-related mortality, supporting the
conclusion of the article by Lindholt et al.1Table 1. Characteristics of Trials and Meta-analyses of Outcomes
Viborg Country
Trial1
Western Australia
Triala
MASSb Chichester Trial,
Menc,d
Combined
Age (y) 64e73 65e83 65e74 65e80 e
Total participants (No) 12 639 38 704 67 800 6433 125 576
Follow-up (y) 9.6e 3.6e 4.1f 10c/2.5d,f e
Attended screening (%) 77 63 80 73 74
Outcome ascertained (%) 100 NR 99 NR e
Quality (USPSTF criteria) Fair Fair Good Fair e
AAA-related mortality (n/Ng [%])
Screening 14/6333 (0.221) 18/19352 (0.093) 65/33839 (0.192) 24/3000 (0.800)c 121/62524 (0.194)
Control 51/6306 (0.809) 25/19352 (0.129) 113/33961 (0.333) 31/3058 (1.014)c 220/62677 (0.351)
OR (95% CI) 0.27 (0.15e0.49) 0.72 (0.39e1.32) 0.58 (0.42e0.78) 0.79 (0.46e1.34) 0.55 (0.37e0.83)
All-cause mortality (n/Ng [%])
Screening 2184/6333 (34.5) 2232/19352 (11.5) 3750/33839 (11.1) 532/3205 (16.6)d 8698/62729 (13.9)
Control 2234/6306 (35.4) 2571/19352 (13.3) 3855/33961 (11.4) 508/3228 (15.7)d 9168/62847 (14.6)
OR (95% CI) 0.96 (0.89e1.03) 0.85 (0.80e0.90) 0.97 (0.93e1.02) 1.07 (0.93e1.22) 0.95 (0.87e1.03)
MASS, Multicentre Aneurysm Screening Study; NR, not reported; AAA, abdominal aortic aneurysm; OR, odds ratio; CI, confidence
interval; USPSTF, U.S. Preventive Services Task Force.
a BMJ 2004;329:1259.
b Lancet 2002;360:1531e1539.
c Br J Surg 2002;89:861e864.
d Br J Surg 1995;82:1066e1070.
e Median.
f Mean.
g Number of deaths/number of participants.
in Raynaud’s disease cases seem to warrant the belief
that surgical control in this disease is an accomplished
fact’’. However, in the same volume of the Journal,
Gask2 of London was more cautious ‘‘. the immedi-
ate results are good. As regards the late results,
the same cannot be said without qualification’’.
Subsequently it was the more cautious view which
prevailed and sympathectomy for Raynaud’s disease
was largely abandoned.
In a longterm observational study of 571 cases of
Raynaud’s 140 patients had had an open sympathec-
tomy; of these some 18% reported lasting benefit but
in 66% of the total there had been no improvement
beyond one year.3
ETS is only a minimally invasive way of performing
upper dorsal sympathectomy and just because it is eas-
ier to carry out does not alter its place in the treatment of
Raynaud’s disease. The authors of this paper are to be
commended forhighlighting thehigh ‘‘regret rate’’ after
ETS for Raynaud’s and for their realistic advice that it
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I was very interested in this paper investigating thora-
scopic sympathectomy (ETS) in Raynaud’s disease.
However lessons may also be learned from the older
‘‘open’’ approaches.
Writing over 70 years ago, the Mayo clinic group
under Adson1 were supremely confident ‘‘.the strik-
ing, maintained, and unequivocal therapeutic effects
of lumbar and dorsal sympathetic ganglionectomy
should only be a last resort in the most severe cases.
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